Camelot Portfolios’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Camelot Portfolios's BCAT Position: Q2 2026 in Review
Camelot Portfolios sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2026, closing a stake of 19,500 shares — an estimated $276K sold.
Camelot Portfolios first reported a position in BCAT in Q4 2022 and held it in 14 quarters. The position peaked at $404K in Q2 2023. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.
- Camelot Portfolios reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2026 after selling out during the quarter.
- Camelot Portfolios sold 19,500 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $276K.
- Camelot Portfolios first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and held it in 14 quarters.
- Camelot Portfolios's BlackRock Capital Allocation Term Trust position peaked at $404K in Q2 2023.
- 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.
Based on Camelot Portfolios's 13F filing for Q2 2026, filed 17 Jul 2026.